A hemizygous p.R204Q mutation in the ALAS2 gene underlies X-linked sideroblastic anemia in an adult Chinese Han man

被引:2
作者
Huang, Jinbo [1 ]
Ge, Meili [1 ]
Shao, Yingqi [1 ]
Wang, Min [1 ]
Jin, Peng [1 ]
Huo, Jiali [1 ]
Li, Xingxin [1 ]
Zhang, Jing [1 ]
Nie, Neng [1 ]
Zheng, Yizhou [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China
基金
中国国家自然科学基金;
关键词
ALAS2; X-linked sideroblastic anemia; Hemizygous;
D O I
10.1186/s12920-021-00950-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background X-linked sideroblastic anemia (XLSA) is the most common form of congenital sideroblastic anemia (CSA), and is associated with the mutations in the 5-aminolevulinate synthase 2 (ALAS2). The genetic basis of more than 40% of CSA cases remains unknown. Methods A two-generation Chinese family with XLSA was studied by next-generation sequencing to identify the underlying CSA-related mutations. Results In the study, we identified a missense ALAS2 R204Q mutation in a hemizygous Chinese Han man and in his heterozygous daughter. The male proband presented clinical manifestations at 38 years old and had a good response to pyridoxine. Conclusions XLSA, as a hereditary disease, can present clinical manifestations later in lives, for adult male patients with ringed sideroblasts and hypochromic anemia, it should be evaluated with gene analyses to exclude CSA.
引用
收藏
页数:5
相关论文
共 17 条
[1]   Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans [J].
Astner, I ;
Schulze, JO ;
van den Heuvel, J ;
Jahn, D ;
Schubert, WD ;
Heinz, DW .
EMBO JOURNAL, 2005, 24 (18) :3166-3177
[2]   Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release [J].
Bailey, Henry J. ;
Bezerra, Gustavo A. ;
Marcero, Jason R. ;
Padhi, Siladitya ;
Foster, William R. ;
Rembeza, Elzbieta ;
Roy, Arijit ;
Bishop, David F. ;
Desnick, Robert J. ;
Bulusu, Gopalakrishnan ;
Dailey, Harry A., Jr. ;
Yue, Wyatt W. .
NATURE COMMUNICATIONS, 2020, 11 (01)
[3]   Sideroblastic Anemia Diagnosis and Management [J].
Bottomley, Sylvia S. ;
Fleming, Mark D. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (04) :653-+
[4]   Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing [J].
Cazzola, Mario ;
Malcovati, Luca .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, :19-25
[5]   ASSIGNMENT OF HUMAN ERYTHROID DELTA-AMINOLEVULINATE SYNTHASE (ALAS2) TO A DISTAL SUBREGION OF BAND XP11.21 BY PCR ANALYSIS OF SOMATIC-CELL HYBRIDS CONTAINING X - AUTOSOME TRANSLOCATIONS [J].
COTTER, PD ;
WILLARD, HF ;
GORSKI, JL ;
BISHOP, DF .
GENOMICS, 1992, 13 (01) :211-212
[6]   LATE-ONSET X-LINKED SIDEROBLASTIC ANEMIA [J].
COTTER, PD ;
MAY, A ;
FITZSIMONS, EJ ;
HOUSTON, T ;
WOODCOCK, BE ;
ALSABAH, AI ;
WONG, L ;
BISHOP, DF .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :2090-2096
[7]  
COX TC, 1990, AM J HUM GENET, V46, P107
[8]   A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review [J].
Fujiwara, Tohru ;
Fukuhara, Noriko ;
Ichikawa, Satoshi ;
Kobayashi, Masahiro ;
Okitsu, Yoko ;
Onishi, Yasushi ;
Furuyama, Kazumichi ;
Harigae, Hideo .
ANNALS OF HEMATOLOGY, 2017, 96 (11) :1955-1957
[9]   Late-onset X-linked sideroblastic anemia following hemodialysis [J].
Furuyama, K ;
Harigae, H ;
Kinoshita, C ;
Shimada, T ;
Miyaoka, K ;
Kanda, C ;
Maruyama, Y ;
Shibahara, S ;
Sassa, S .
BLOOD, 2003, 101 (11) :4623-4624
[10]   Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia [J].
Furuyama, Kazumichi ;
Kaneko, Kiriko .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) :44-54